abstract |
A Fas ligand solubilization inhibitor which comprises, as the activeningredient, a compound of the generic formula (I) having a matrixnmetalloproteinase inhibitory activity or its pharmaceutically acceptable salt. Thendrug is useful in the prevention or treatment of diseases caused by solubilizednFas ligand, such as hepatitis, GVHD, AIDS, autoimmune diseases, etc. |